These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine. Shabsigh R, Patrick DL, Rowland DL, Bull SA, Tesfaye F, Rothman M. BJU Int; 2008 Sep 30; 102(7):824-8. PubMed ID: 18647300 [Abstract] [Full Text] [Related]
3. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. McMahon C, Kim SW, Park NC, Chang CP, Rivas D, Tesfaye F, Rothman M, Aquilina J, Dapoxetine 3003 Study Investigators. J Sex Med; 2010 Jan 30; 7(1 Pt 1):256-68. PubMed ID: 19878447 [Abstract] [Full Text] [Related]
4. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. McMahon CG, Giuliano F, Dean J, Hellstrom WJ, Bull S, Tesfaye F, Sharma O, Rivas DA, Aquilina JW. J Sex Med; 2013 Sep 30; 10(9):2312-25. PubMed ID: 23845016 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, Miloslavsky M, Kell S, Dapoxetine Study Group. Lancet; 2006 Sep 09; 368(9539):929-37. PubMed ID: 16962882 [Abstract] [Full Text] [Related]
18. [Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation]. Yang L, Luo L, Chen XF, Fan JH, Liu RM, Wang XN, Nan XY, Zhang Y, Lin XF, Wang MZ, Xing JP, Yang ZS, Jian BL, He H, Wu DP, He DL. Zhonghua Nan Ke Xue; 2015 Oct 09; 21(10):892-5. PubMed ID: 26665676 [Abstract] [Full Text] [Related]